{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T07:55:30Z","timestamp":1793778930746,"version":"4.6.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T00:00:00Z","timestamp":1604880000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T00:00:00Z","timestamp":1604880000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hydroa vacciniforme-like lymphoproliferative disorder (HVLPD) is a rare Epstein\u2013Barr virus (EBV)-associated lymphoproliferative disease. The disease course of HVLPD varies from an indolent course to progression to aggressive lymphoma. We investigated the characteristics of HVLPD in Korean patients. HVLPD patients at Seoul National University Hospital between 1988 and 2019 were retrospectively analyzed. This study included 26 HVLPD patients who all presented with recurrent papulovesicular and necrotic eruption on the face, neck, and extremities. EBV was detected from the skin tissues of all patients. HVLPD was diagnosed during childhood (age &lt;\u200918\u00a0years) in seven patients (26.9%) and in adulthood (age \u2265\u200918\u00a0years) in 19 cases (73.1%). The median age at diagnosis was 24.0\u00a0years (range 7\u201370\u00a0years). HVLPD has various clinical courses, from an indolent course to progression to systemic lymphoma. Fourteen patients (53.8%) developed lymphoma: systemic EBV-positive T-cell lymphoma (n\u2009=\u20099, 34.6%); extranodal natural killer\/T-cell lymphoma, nasal type (n\u2009=\u20093, 11.5%); aggressive natural killer\/T-cell leukemia (n\u2009=\u20091, 3.8%); and EBV-positive Hodgkin lymphoma (n\u2009=\u20091, 3.8%). Mortality due to HVLPD occurred in five patients (26.3%) in the adult group, while it was one patient (14.3%) in the child group. As lymphoma progression and mortality occur not only in childhood but also in adulthood, adult-onset cases may need more careful monitoring.<\/jats:p>","DOI":"10.1038\/s41598-020-76345-2","type":"journal-article","created":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T11:05:02Z","timestamp":1604919902000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Hydroa vacciniforme-like lymphoproliferative disorder in Korea"],"prefix":"10.1038","volume":"10","author":[{"given":"Byeol","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keunyoung","family":"Hur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jungyoon","family":"Ohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Min","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon Kyung","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You Chan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Je-Ho","family":"Mun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,9]]},"reference":[{"key":"76345_CR1","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow, S. H. et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127, 2375\u20132390 (2016).","journal-title":"Blood"},{"key":"76345_CR2","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/PAP.0000000000000208","volume":"26","author":"U Sundram","year":"2019","unstructured":"Sundram, U. Cutaneous lymphoproliferative disorders: What\u2019s new in the revised 4th edition of the World Health Organization (WHO) classification of lymphoid neoplasms. Adv. Anat. Pathol. 26, 93\u2013113 (2019).","journal-title":"Adv. Anat. Pathol."},{"key":"76345_CR3","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.jaad.2019.01.011","volume":"81","author":"Y Liu","year":"2019","unstructured":"Liu, Y., Ma, C., Wang, G. & Wang, L. Hydroa vacciniforme-like lymphoproliferative disorder: Clinicopathologic study of 41 cases. J. Am. Acad. Dermatol. 81, 534\u2013540 (2019).","journal-title":"J. Am. Acad. Dermatol."},{"key":"76345_CR4","doi-asserted-by":"publisher","DOI":"10.1097\/DAD.0000000000001494","author":"KA Lyapichev","year":"2019","unstructured":"Lyapichev, K. A., Sukswai, N., Wang, X. I., Khoury, J. D. & Medeiros, L. J. Hydroa vacciniforme\u2013like lymphoproliferative disorder with progression to EBV+ cytotoxic peripheral T-cell lymphoma. Am. J. Dermatopathol. https:\/\/doi.org\/10.1097\/DAD.0000000000001494 (2019) (Epub ahead of print).","journal-title":"Am. J. Dermatopathol."},{"key":"76345_CR5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/DAD.0000000000001229","volume":"41","author":"PF Wen","year":"2019","unstructured":"Wen, P. F. et al. Comparative study of the clinical pathology, immunophenotype, Epstein-Barr virus infection status, and gene rearrangements in adult and child patients with hydroa vacciniforme-like lymphoproliferative disorder. Am. J. Dermatopathol. 41, 7\u201315 (2019).","journal-title":"Am. J. Dermatopathol."},{"key":"76345_CR6","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/pin.12549","volume":"67","author":"K Kai","year":"2017","unstructured":"Kai, K. et al. Autopsy case of systemic EBV-positive T-cell lymphoma of childhood with marked hepatomegaly in a middle-aged man. Pathol. Int. 67, 431\u2013433 (2017).","journal-title":"Pathol. Int."},{"key":"76345_CR7","doi-asserted-by":"publisher","first-page":"209","DOI":"10.5021\/ad.2009.21.2.209","volume":"21","author":"SY Huh","year":"2009","unstructured":"Huh, S. Y., Choi, M. & Cho, K. H. A case of Epstein\u2013Barr virus-associated hydroa vacciniforme. Ann. Dermatol. 21, 209\u2013212 (2009).","journal-title":"Ann. Dermatol."},{"key":"76345_CR8","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1046\/j.1365-2133.1997.18631933.x","volume":"137","author":"KH Cho","year":"1997","unstructured":"Cho, K. H. et al. Epstein\u2013Barr virus-associated lymphoproliferative eruption with progression to large granular lymphocytic leukaemia. Br. J. Dermatol. 137, 426\u2013430 (1997).","journal-title":"Br. J. Dermatol."},{"key":"76345_CR9","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/j.1365-2133.2004.06038.x","volume":"151","author":"KH Cho","year":"2004","unstructured":"Cho, K. H. et al. Epstein\u2013Barr virus-associated lymphoproliferative lesions presenting as a hydroa vacciniforme-like eruption: an analysis of six cases. Br. J. Dermatol. 151, 372\u2013380 (2004).","journal-title":"Br. J. Dermatol."},{"key":"76345_CR10","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1046\/j.1365-2133.1996.99812.x","volume":"134","author":"KH Cho","year":"1996","unstructured":"Cho, K. H. et al. An Epstein\u2013Barr virus-associated lymphoproliferative lesion of the skin presenting as recurrent necrotic papulovesicles of the face. Br. J. Dermatol. 134, 791\u2013796 (1996).","journal-title":"Br. J. Dermatol."},{"key":"76345_CR11","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1046\/j.1365-2230.2001.00805.x","volume":"26","author":"KH Cho","year":"2001","unstructured":"Cho, K. H. et al. Epstein\u2013Barr virus-associated peripheral T-cell lymphoma in adults with hydroa vacciniforme-like lesions. Clin. Exp. Dermatol. 26, 242\u2013247 (2001).","journal-title":"Clin. Exp. Dermatol."},{"key":"76345_CR12","doi-asserted-by":"publisher","first-page":"789","DOI":"10.5021\/ad.2015.27.6.789","volume":"27","author":"SE Jung","year":"2015","unstructured":"Jung, S. E., Cho, K. H., Lee, M. W. & Kim, Y. C. Hydroa vacciniforme-like eruption associated with Epstein\u2013Barr virus infection in an older adult. Ann. Dermatol. 27, 789\u2013791 (2015).","journal-title":"Ann. Dermatol."},{"key":"76345_CR13","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1080\/10428194.2016.1179297","volume":"58","author":"JH Paik","year":"2017","unstructured":"Paik, J. H. et al. Clinicopathological categorization of Epstein\u2013Barr virus-positive T\/NK-cell lymphoproliferative disease: An analysis of 42 cases with an emphasis on prognostic implications. Leuk. Lymphoma. 58, 53\u201363 (2017).","journal-title":"Leuk. Lymphoma."},{"key":"76345_CR14","unstructured":"Bazin E. Le\u00e7ons th\u00e9oriques et cliniques sur les affections g\u00e9n\u00e9riques de la peau. (Adrien Delahaye, 1862)."},{"key":"76345_CR15","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/S0190-9622(00)90127-0","volume":"42","author":"G Gupta","year":"2000","unstructured":"Gupta, G., Man, I. & Kemmett, D. Hydroa vacciniforme: A clinical and follow-up study of 17 cases. J. Am. Acad. Dermatol. 42, 208\u2013213 (2000).","journal-title":"J. Am. Acad. Dermatol."},{"key":"76345_CR16","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1182\/blood.2019001031","volume":"133","author":"L Quintanilla-Martinez","year":"2019","unstructured":"Quintanilla-Martinez, L. & Fend, F. Deciphering hydroa vacciniforme. Blood 133, 2735\u20132737 (2019).","journal-title":"Blood"},{"key":"76345_CR17","doi-asserted-by":"publisher","first-page":"5019","DOI":"10.1182\/blood-2011-01-293050","volume":"117","author":"E Campo","year":"2011","unstructured":"Campo, E. et al. The 2008 WHO classification of lymphoid neoplasms and beyond: Evolving concepts and practical applications. Blood 117, 5019\u20135032 (2011).","journal-title":"Blood"},{"key":"76345_CR18","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber, D. A. et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127, 2391\u20132405 (2016).","journal-title":"Blood"},{"key":"76345_CR19","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3389\/fped.2019.00071","volume":"7","author":"WY Kim","year":"2019","unstructured":"Kim, W. Y., Montes-Mojarro, I. A., Fend, F. & Quintanilla-Martinez, L. Epstein\u2013Barr virus-associated T and NK-cell lymphoproliferative diseases. Front. Pediatr. 7, 71 (2019).","journal-title":"Front. Pediatr."},{"key":"76345_CR20","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1080\/10428194.2019.1699080","volume":"61","author":"JI Cohen","year":"2020","unstructured":"Cohen, J. I. et al. Epstein\u2013Barr virus NK and T cell lymphoproliferative disease: Report of a 2018 international meeting. Leuk. Lymphoma. 61, 808\u2013819 (2020).","journal-title":"Leuk. Lymphoma."},{"key":"76345_CR21","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.humpath.2015.03.002","volume":"46","author":"YK Jeon","year":"2015","unstructured":"Jeon, Y. K., Kim, J. H., Sung, J. Y., Han, J. H. & Ko, Y. H. Epstein\u2013Barr virus-positive nodal T\/NK-cell lymphoma: An analysis of 15 cases with distinct clinicopathological features. Hum. Pathol. 46, 981\u2013990 (2015).","journal-title":"Hum. Pathol."},{"key":"76345_CR22","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1111\/ijd.14050","volume":"57","author":"V Long","year":"2018","unstructured":"Long, V., Liang, M. W. & Tan, S. H. Hydroa vacciniforme-like lymphoproliferative disorder in an elderly Chinese patient and a literature review of adult cases. Int. J. Dermatol. 57, 1283\u20131292 (2018).","journal-title":"Int. J. Dermatol."},{"key":"76345_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.11.031","author":"R Xue","year":"2019","unstructured":"Xue, R. et al. Hydroa vacciniforme-like lymphoma: Clinicopathological description, treatment and outcome. J. Am. Acad. Dermatol. Preprint at https:\/\/doi.org\/10.1016\/j.jaad.2019.11.031 (2019).","journal-title":"J. Am. Acad. Dermatol. Preprint at"},{"key":"76345_CR24","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1182\/blood.2018893750","volume":"133","author":"JI Cohen","year":"2019","unstructured":"Cohen, J. I. et al. Hydroa vacciniforme-like lymphoproliferative disorder: An EBV disease with a low risk of systemic illness in whites. Blood 133, 2753\u20132764 (2019).","journal-title":"Blood"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-76345-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-76345-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-76345-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T22:38:07Z","timestamp":1670366287000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-76345-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,9]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["76345"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-76345-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,9]]},"assertion":[{"value":"6 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19294"}}